OCADLIKOVA, DARINA
 Distribuzione geografica
Continente #
NA - Nord America 1.725
EU - Europa 1.162
AS - Asia 537
AF - Africa 55
OC - Oceania 5
SA - Sud America 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 3.490
Nazione #
US - Stati Uniti d'America 1.719
GB - Regno Unito 340
SE - Svezia 257
CN - Cina 176
IT - Italia 157
SG - Singapore 136
DE - Germania 119
IN - India 90
VN - Vietnam 79
IE - Irlanda 55
UA - Ucraina 40
RU - Federazione Russa 37
FR - Francia 36
BG - Bulgaria 32
ZA - Sudafrica 25
JO - Giordania 24
EE - Estonia 20
FI - Finlandia 19
BE - Belgio 18
TG - Togo 17
CH - Svizzera 9
ID - Indonesia 9
CI - Costa d'Avorio 7
CA - Canada 6
LB - Libano 6
NL - Olanda 5
JP - Giappone 4
NG - Nigeria 4
AU - Australia 3
CZ - Repubblica Ceca 3
ES - Italia 3
IR - Iran 3
RO - Romania 3
CL - Cile 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
TR - Turchia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AT - Austria 1
BD - Bangladesh 1
BR - Brasile 1
EG - Egitto 1
EU - Europa 1
GR - Grecia 1
HK - Hong Kong 1
HU - Ungheria 1
KR - Corea 1
KW - Kuwait 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LI - Liechtenstein 1
LT - Lituania 1
MY - Malesia 1
PE - Perù 1
PL - Polonia 1
PT - Portogallo 1
SC - Seychelles 1
UZ - Uzbekistan 1
Totale 3.490
Città #
Southend 322
Fairfield 222
Chandler 210
Singapore 126
Ashburn 117
Wilmington 92
Ann Arbor 91
Woodbridge 84
Santa Clara 82
Houston 78
Seattle 76
Princeton 72
Cambridge 59
Dublin 55
Bologna 40
Boardman 38
Sofia 32
Westminster 27
Nanjing 26
Amman 24
Dong Ket 23
Padova 23
Jacksonville 20
Brussels 18
Helsinki 18
Jinan 17
Lomé 17
Hyderabad 16
Berlin 15
Redwood City 15
San Diego 15
New York 14
Pune 14
Beijing 11
Shenyang 11
Hebei 10
Bremen 9
Jakarta 9
Benevento 8
Bern 8
Abidjan 7
Redmond 7
Tianjin 7
Florence 6
Mülheim 6
Nanchang 6
Zhengzhou 6
Changsha 5
San Francisco 5
Turin 5
Wuhan 5
Abeokuta 4
Dearborn 4
Gradara 4
Jiaxing 4
Medford 4
Osimo 4
Saint Petersburg 4
Taiyuan 4
Tokyo 4
Toronto 4
York 4
Castellammare del Golfo 3
Frankfurt Am Main 3
Guangzhou 3
Haikou 3
Hangzhou 3
Lanzhou 3
London 3
Milan 3
Ningbo 3
Norwalk 3
Phoenix 3
Prineville 3
Washington 3
Amsterdam 2
Andover 2
Auckland 2
Boydton 2
Castenaso 2
Cervia 2
Charlotte 2
Chicago 2
Crevalcore 2
Den Haag 2
Des Moines 2
El Cerrito 2
Harbin 2
Kemerovo 2
Leawood 2
Los Angeles 2
Monza 2
Moscow 2
Naples 2
New Delhi 2
Ottawa 2
Paderno Dugnano 2
Paris 2
Qingdao 2
Ravenna 2
Totale 2.362
Nome #
CD103 marks a subset of human CD34+-derived langerin+ dendritic cells that induce T-regulatory cells via indoleamine 2,3-dioxygenase-1 192
Indoleamine 2,3-dioxygenase-expressing leukemic dendritic cells impair a leukemia-specific immune response by inducing potent T regulatory cells. 163
ATP release from chemotherapy-treated dying leukemia cells Elicits an immune suppressive effect by increasing regulatory T cells and Tolerogenic dendritic cells 156
Flow cytometry analysis of T-cell subsets in cerebrospinal fluid of narcolepsy type 1 patients with long-lasting disease 144
Extracellular ATP exerts opposite effects on activated and regulatory CD4 + T cells via purinergic P2 receptor activation 133
Larger size of donor alloreactive NK cell repertoire correlates with better response to NK cell immunotherapy in elderly acute myeloid leukemia patients 133
Mesenchymal stromal cells from myelodysplastic and acute myeloid leukemia patients display in vitro reduced proliferative potential and similar capacity to support leukemia cell survival 132
Immunosenescence and immunotherapy in elderly acute myeloid leukemia patients: Time for a biology-driven approach 130
Chemotherapy-Induced Tumor Cell Death at the Crossroads Between Immunogenicity and Immunotolerance: Focus on Acute Myeloid Leukemia 130
In vitro activation of cytotoxic T-lymphocytes by hTERT-pulsed dendritic cells. 128
Donor Natural Killer (NK) Alloreactivity Predicts Long-Term Relapse-Free Survival in Acute Myeloid Leukemia Patients Undergoing Immunotherapy with NK Cells 126
PGE2-induced IDO1 inhibits the capacity of fully mature DCs to elicit an in vitro antileukemic immune response 121
The more, the better: "Do the right thing" for natural killer immunotherapy in acute myeloid leukemia 121
Generation of myeloma-specific T cells using dendritic cells loaded with MUC1- and hTERT- drived nonapeptides or myeloma cell apoptotic bodies. 118
The SOCS3-independent expression of IDO2 supports the homeostatic generation of T regulatory cells by human dendritic cells. 118
Efficacy and safety of Id-protein-loaded dendritic cell vaccine in patients with multiple myeloma – Phase II study results 110
The role of the immunosuppressive microenvironment in acute myeloid leukemia development and treatment. 109
Individual myeloma-specific T-cell clones eliminate tumour cells and correlate with clinical outcomes in patients with multiple myeloma. 107
Isolation and expansion of allogeneic myeloma-specific interferon-gamma producing T cells for adoptive immunotherapy. 106
Long-Term Outcome After Adoptive Immunotherapy With Natural Killer Cells: Alloreactive NK Cell Dose Still Matters 106
Immune characterization in Narcolepsy Type 1. 102
Indoleamine 2,3-Dioxygenase (IDO) Is Associated with High Incidence of Chemorefractory Disease in Acute Myeloid Leukemia (AML) Patients 101
Generation of dendritic cells using cell culture bags--description of a method and review of literature. 96
Selective depletion of alloreactive T cells and study of anti-tumor activity of specific T cell clones in patients with leukemia. 91
Dendritic cell counts and their subsets during treatment of multiple myeloma. 88
The preparation of anticancer vaccine for patients with multiple myeloma on the base of monoclonal immunoglobulin loaded dendritic cells. 88
Flow cytometry T cell profiling in a recent-onset narcoleptic type 1 child: a case report 80
The preparation of myeloma-specific T cells activated with dendritic cells loaded with nonapeptides derived from mucin protein MUC1 and catalytic subunit of telomerase hTERT. 76
Sunitinib Exerts In Vitro Immunomodulatory Activity on Sarcomas via Dendritic Cells and Synergizes With PD-1 Blockade 71
Long-Term Outcome After Adoptive Immunotherapy With Natural Killer Cells: Alloreactive NK Cell Dose Still Matters 61
A screening of antineoplastic drugs for acute myeloid leukemia reveals contrasting immunogenic effects of etoposide and fludarabine 53
Release of IFNg by Acute Myeloid Leukemia Cells Remodels Bone Marrow Immune Microenvironment by Inducing Regulatory T Cells 52
An IDO1-related immune gene signature predicts overall survival in acute myeloid leukemia 34
Induction of regulatory T Cells by dendritic cells through indoleamine 2,3-dioxygenase: a potent mechanism of acquired peripheral tolerance 2
Totale 3.578
Categoria #
all - tutte 9.484
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.484


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020505 0 0 0 0 0 66 96 90 106 64 30 53
2020/2021430 83 28 3 11 37 39 16 21 40 21 13 118
2021/2022620 28 26 43 33 71 35 10 56 28 42 141 107
2022/2023847 120 132 51 103 46 73 36 57 134 12 52 31
2023/2024244 20 36 9 34 21 73 13 4 9 5 17 3
2024/2025407 40 124 43 56 118 26 0 0 0 0 0 0
Totale 3.578